Organovo and Samsara Sciences partner with ARMI | BioFabUSA to connect with a valuable network of resources in biofabrication.
ARMI's mission is to make practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones. In help achieve this mission, one of the BioFabUSA program's manufacturing goals is to make practical end-to-end automated biofabrication lines. These lines would ideally incorporate process analytical technologies ("PATs") to aid in the design, analysis and control of biomanufacturing processes through measurement of parameters that are essential to tissue engineering and regenerative medicine. ARMI | BioFabUSA envisions a single manufacturing line that includes the use of multiple bioreactors that can be used for any tissue and include basic non-invasive sensors for real-time monitoring of samples. It is with the goal of a system like this in mind that the Spring 2018 Technical Project Call and TissueFoundry Technology Call are based.
The required skills for an emerging industry, like biofabrication, will inevitably shift over time as technologies and manufacturing platforms are implemented to improve commercialization methods within the field; however, there will be a constant need for innovation by highly trained operators, technicians, scientists and engineers in order to develop new solutions and technologies and manufacturing capabilities mature over time. To that end and in order to advance the industry forward, BioFabUSA is collecting industry input on skills gaps and training needs, which will change as necessary over time as the standard practices evolve.